Document Detail


L-carnitine adjuvant therapy in essential hypertension.
MedLine Citation:
PMID:  7924177     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was undertaken to demonstrate L-carnitine therapeutical effect in patients with essential hypertension. Two groups were tested, A and B. First group (A) was split in two subgroups, A1 and A2. Subgroup A1 included 14 patients with essential hypertension, they were treated with antihypertensive drugs and L-carnitine. Subgroup A2 included 14 patients with essential hypertension, that were treated with antihypertensive drugs only. Group B included 9 patients with essential hypertension and they were treated with L-carnitine only. Subgroup A1 patients were treated with oral L-carnitine 2 gm per day for 22 weeks; group B patients were treated with the same dose for 10 weeks. The asthenia symptom was evaluated, a resting and dynamic E.C.G. was carried out, serum triglycerides, serum total and high-density lipoprotein (HDL) cholesterol, serum sodium and potassium, serum creatinine, serum glucose and blood pressure were determined before and at the end of test in group A patients. Test procedure of group B patients included also serum evaluation of apolipoproteins A1 and B and radionuclide angiocardiography. In subgroup A1 patients extrasystoles as well as some electrocardiographic signs of minor changes of ventricular repolarization reversed or diminished, the asthenia symptom was improved significantly and triglyceride values decreased from 148 +/- 15.8 mg/dl to 121 +/- 14.3 mg/dl (p < 0.025).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
V Digiesi; F Cantini; G Bisi; G Guarino; B Brodbeck
Related Documents :
15337617 - Clinical characterization of idiopathic intracranial hypertension at the detroit medica...
3718127 - Episodic dopamine discharge in paroxysmal hypertension. page's syndrome revisited.
2651327 - Long-term clinical results after vasodilator evaluation in patients with primary (unexp...
15177527 - Silent cerebral white matter lesions and cognitive function in middle-aged essential hy...
10037367 - Bladder involvement in behçet's syndrome.
11602907 - Differences in arterial and mixed venous il-6 levels: the lungs as a source of cytokine...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  La Clinica terapeutica     Volume:  144     ISSN:  0009-9074     ISO Abbreviation:  Clin Ter     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-10-21     Completed Date:  1994-10-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372604     Medline TA:  Clin Ter     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  391-5     Citation Subset:  IM    
Affiliation:
Florence University Medical School, Third Institute of Clinical Medicine and Medical Therapy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Carnitine / pharmacology,  therapeutic use*
Chemotherapy, Adjuvant
Cholesterol / blood
Female
Heart Rate / drug effects
Humans
Hypertension / blood,  drug therapy*
Male
Middle Aged
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Triglycerides; 541-15-1/Carnitine; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes in pulse transit time and pulse rate as markers of arousal from sleep in normal subjects.
Next Document:  Aging of the aorta: a morphological study